We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Research Lab to Develop World’s First Neural Device to Restore Memory

By LabMedica International staff writers
Posted on 04 Aug 2014
A USD 2.5 million grant has been awarded to a US research lab to develop an implantable neural device with the ability to record and stimulate neurons within the brain to help restore memory.

The US Department of Defense’s Defense Advanced Research Projects Agency (DARPA) awarded the grant to Lawrence Livermore National Laboratory (LLNL; Livermore, CA, USA). More...
The research builds on the knowledge that memory is a process in which neurons in specific regions of the brain encode information, store it, and retrieve it. Specific types of disorders and injuries, including traumatic brain injury (TBI), Alzheimer’s disease, and epilepsy, disrupt this process and cause memory loss. TBI, specifically, has affected 270,000 military service members since 2000.

The objective of LLNL’s research initiated by LLNL’s Neural Technology group and undertaken in collaboration with the University of California, Los Angeles (UCLA; USA) and Medtronic (Minneapolis, MN, USA) is to develop a device that uses real-time recording and closed-loop stimulation of neural tissues to bridge gaps in the injured brain and restore individuals’ ability to form new memories and access previously formed ones.

The research is funded by DARPA’s Restoring Active Memory (RAM) program. Specifically, the neural technology group are trying to develop a neuromodulation system, an advanced electronics system to modulate neurons, which will investigate areas of the brain associated with memory to understand how new memories are formed. The device will be developed at LLNL’s Center for Bioengineering.

“Currently, there is no effective treatment for memory loss resulting from conditions like TBI,” said LLNL’s project leader Dr. Satinderpall Pannu, director of the LLNL’s Center for Bioengineering, a unique facility dedicated to fabricating biocompatible neural interfaces. “This is a tremendous opportunity from DARPA to leverage Lawrence Livermore’s advanced capabilities to develop cutting-edge medical devices that will change the health care landscape.”

LLNL engineers will devise a miniature, wireless and chronically implantable neural device that will incorporate both single neuron and local field potential recordings into a closed-loop system to implant into TBI patients’ brains. The device implanted into the entorhinal cortex and hippocampus will allow for stimulation and recording from 64 channels located on two high-density electrode arrays. The entorhinal cortex and hippocampus are brain regions associated with memory.

The arrays will connect to an implantable electronics bundle capable of wireless data and power telemetry. An external electronic system worn around the ear will store digital information associated with memory storage and retrieval and provide power telemetry to the implantable package using a custom radiofrequency (RF) coil system.

The device’s electrodes will be integrated with electronics using advanced LLNL integration and 3D packaging technologies, and are designed to last throughout the duration of treatment. The microelectrodes that are the heart of this device are embedded in a biocompatible, flexible polymer. Using the Center for Bioengineering’s capabilities, Dr. Pannu and his team of engineers have achieved 25 patents and many publications during the last 10 years. The team's goal is to build the new prototype device for clinical testing by 2017.

Lawrence Livermore’s collaborators, UCLA and Medtronic, will focus on conducting clinical trials and creating parts and components, respectively. “The RAM program poses a formidable challenge reaching across multiple disciplines from basic brain research to medicine, computing and engineering,” said Itzhak Fried, lead investigator for the UCLA on this project and professor of neurosurgery and psychiatry and biobehavioral sciences at the David Geffen School of Medicine at UCLA and the Semel Institute for Neuroscience and Human Behavior. “But at the end of the day, it is the suffering individual, whether an injured member of the armed forces or a patient with Alzheimer’s disease, who is at the center of our thoughts and efforts.”

LLNL’s work on the Restoring Active Memory program supports President Obama’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative. “Our years of experience developing implantable microdevices, through projects funded by the Department of Energy [DOE], prepared us to respond to DARPA’s challenge,” said Lawrence Livermore engineer Kedar Shah, a project leader in the neural technology group.

Related Links:

Lawrence Livermore National Laboratory
University of California, Los Angeles 
Medtronic



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
POC Immunoassay Analyzer
Procise DX
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Molecular Diagnostics

view channel
Image: Congenital cytomegalovirus can go unnoticed at birth despite later risks to hearing and development (Image Credit: 123RF)

Pooled Saliva PCR Screening Identifies Congenital CMV Missed by Targeted Testing

Congenital cytomegalovirus (cCMV) can be present in newborns who appear healthy and pass routine hearing screening. The infection is one of the most common maternal-to-fetal infections during pregnancy... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.